Linda Yaccarino, who stepped down as CEO of Elon Musk's social media platform X in June 2025, has been appointed as the new chief executive officer of eMed Population Health, a telehealth startup specializing in digital health solutions focused on GLP-1 weight loss drugs. Yaccarino's appointment comes less than a month after her departure from X. eMed Population Health aims to transform healthcare access and chronic condition management through the use of GLP-1 therapies. The company leverages AI-driven technology to provide enterprise solutions that address healthcare costs and improve patient care. Yaccarino expressed enthusiasm about leading eMed's ambitious growth and mission to revolutionize healthcare delivery. This move marks her transition from social media leadership to the digital health sector.